OptimizeRx to Participate at the 33rd Annual Virtual ROTH Conference on March 15-17, 2021
OptimizeRx Corp. (Nasdaq: OPRX), a leading provider of digital
health solutions for life science companies, physicians and
patients, has been invited to present at the 33rd Annual ROTH
Growth Conference being held virtually on March 15-17, 2021.
The conference will feature presentations from public and
private companies across a variety of industry sectors, followed by
one-on-one and small group meetings, as well as expert panels and
fireside chats. Past events have featured more than 550
participating companies and drawn more than 5,000 attendees that
include institutional investors, analysts, family offices and
OptimizeRx pre-recorded video webcast presentation is available
today here and via the investor relations section of the
company’s website at www.optimizerx.com.
OptimizeRx CEO, Will Febbo, will participate in one-on-one
meetings with investors and analysts during the conference. He
plans to discuss the company’s recently reported record 2020
results, with a 76% increase in revenue to $43.3 million largely
driven by what is seen as a permanent shift to more digital
enablement. The company also finished the year with a sales
pipeline of more than $180 million, including enterprise deals
valued at more than $50 million.
To submit a registration request, click here. To schedule a
one-on-one meeting with OptimizeRx, please contact your ROTH
representative. For any questions about the company, contact Ron
Both of CMA at (949) 432-7557 or submit your request here.
About ROTH Capital PartnersROTH Capital
Partners, LLC “ROTH” is a relationship-driven investment bank
focused on serving emerging growth companies and their investors.
As a full-service investment bank, ROTH provides capital raising,
M&A advisory, analytical research, trading, market-making
services and corporate access. Headquartered in Newport Beach, CA,
ROTH is privately held and employee owned. For more information on
ROTH, please visit www.roth.com.
About OptimizeRxOptimizeRx is a digital
health company that provides communications solutions for life
science companies, physicians and patients. Connecting over half of
healthcare providers in the U.S. and millions of patients
through a proprietary network, the OptimizeRx digital
health platform helps patients afford and stay on medications. The
platform unlocks new patient and physician touchpoints for life
science companies along the patient journey, from point-of-care, to
retail pharmacy, through mobile patient engagement.
For more information, follow the company
on Twitter, LinkedIn or
Important Cautions Regarding Forward-Looking
Statements This press release contains forward-looking
statements within the definition of Section 27A of the Securities
Act of 1933, as amended, and such as in section 21E of the
Securities Act of 1934, as amended. These forward-looking
statements should not be used to make an investment decision. The
words 'estimate,' 'possible' and 'seeking' and similar expressions
identify forward-looking statements, which speak only as to the
date the statement was made. The company undertakes no obligation
to publicly update or revise any forward-looking statements,
whether because of new information, future events, or otherwise.
Forward-looking statements are inherently subject to risks and
uncertainties, some of which cannot be predicted, or quantified.
Future events and actual results could differ materially from those
set forth in, contemplated by, or underlying the forward-looking
statements. The risks and uncertainties to which forward-looking
statements are subject include, but are not limited to, the effect
of government regulation, competition, and other material
OptimizeRx ContactDoug Baker, CFOTel (248)
Media Relations ContactMaira Alejandra, Media
Relations ManagerTel (754) firstname.lastname@example.org
Investor Relations ContactRon Both, CMATel
(949) 432-7557Email Contact